Lite Strategy, Inc. (LITS): EBITDA
-$17.09M
Year ended 2025-06-30
-$58.09M
Trailing 12 months to 2026-03-31
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | -$17.09M | n/m | 2025-09-26, From 2024-07-01 |
| 2024-06-30 | $14.93M | n/m | 2025-09-26, From 2023-07-01 |
| 2023-06-30 | -$36.38M | n/m | 2024-09-19, From 2022-07-01 |
| 2022-06-30 | -$75.16M | n/m | 2023-09-26, From 2021-07-01 |
| 2021-06-30 | -$60.14M | n/m | 2022-09-08, From 2020-07-01 |
| 2020-06-30 | -$25.59M | n/m | 2022-09-08, From 2019-07-01 |
| 2019-06-30 | -$46.16M | n/m | 2022-05-23, From 2018-07-01 |
| 2018-06-30 | -$28.53M | n/m | 2020-09-09, From 2017-07-01 |
| 2017-06-30 | $2.47M | n/m | 2019-08-28, From 2016-07-01 |
| 2016-06-30 | -$20.95M | n/m | 2018-08-30, From 2015-07-01 |
| 2015-06-30 | -$32.71M | n/m | 2017-09-05, From 2014-07-01 |
| 2014-06-30 | -$27.18M | n/m | 2016-09-06, From 2013-07-01 |
| 2013-06-30 | -$11.18M | n/m | 2015-09-02, From 2012-07-01 |
| 2012-06-30 | -$8.38M | n/a | 2014-09-09, From 2011-07-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | 2025-06-30 | -$17.09M | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$4.01M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $38.59M | +12.5% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$18.06M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$224.0K | n/m |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $3.16B | +317.9% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $270.0K | n/m |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | -$21.57M | n/m |
| Lifevantage Corp (LFVN) | 2026-06-30 | $8.87M | -42.2% |
Compare LITS, TXMD, NATR, LSTA side by side · Screen every company in Pharmaceutical Preparations ↗